- Home
- RNA vs III Comparison
RNA vs III Comparison
Compare RNA & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNA | III |
|---|---|---|
| Founded | 2012 | 2006 |
| Country | United States | United States |
| Employees | N/A | 1500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 227.6M | 250.9M |
| IPO Year | 2025 | 2006 |
Fundamental Metrics
Financial Performance| Metric | RNA | III |
|---|---|---|
| Price | $13.72 | $4.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 1 |
| Target Price | ★ $69.26 | $5.50 |
| AVG Volume (30 Days) | ★ 381.5K | 224.7K |
| Earning Date | 01-01-0001 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.42% |
| EPS Growth | N/A | ★ 216.67 |
| EPS | N/A | ★ 0.19 |
| Revenue | N/A | ★ $192,745,000.00 |
| Revenue This Year | $88.12 | $3.85 |
| Revenue Next Year | $18.11 | $4.34 |
| P/E Ratio | ★ N/A | $21.42 |
| Revenue Growth | N/A | ★ 4.51 |
| 52 Week Low | $11.95 | $3.43 |
| 52 Week High | $73.06 | $6.45 |
Technical Indicators
Market Signals| Indicator | RNA | III |
|---|---|---|
| Relative Strength Index (RSI) | 15.22 | 45.39 |
| Support Level | $13.06 | N/A |
| Resistance Level | $72.89 | $5.14 |
| Average True Range (ATR) | 0.50 | 0.13 |
| MACD | 2.01 | 0.06 |
| Stochastic Oscillator | 74.12 | 87.14 |
Price Performance
Historical ComparisonAbout RNA Avidity Biosciences Inc.
Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.
About III Information Services Group Inc.
Information Services Group Inc is a U.S.-based technology insight, market intelligence, and advisory services firm. It principally offers digital transformation services, such as automation and cloud & data analytics; managed governance; network carrier services; technology plan and operations design; changes management; market intelligence & technology research and analysis. It operates in one segment, fact-based sourcing advisory services. Its geographical segments are the Americas, Europe, and Asia-pacific, out of which maximum revenue is derived from Americas.